thSOUTH SAN FRANCISCO, Calif., Jan. 11, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including an overview of key corporate objectives for 2026. The company will review these updates during its presentation at the 44 Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 3:45pm PST. "2025 was a year of execution, marked by broad pipeline advancement, commercial readiness activities for darovasertib, ...